TTOO — T2 Biosystems Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.02m
- $9.86m
- $7.19m
Brief: T2 Biosystems Sees FY 2023 Total Sepsis & Related Product Rev Of $9.5 Mln To $10.5 Mln
Brief: T2 Biosystems Announces Conversion Of Approximately Twenty Percent Of CRG Term Loan Into Equity
Zuckerberg-Musk fight is on: Meta launches 'Twitter Killer' Threads app (updated)
Zuckerberg-Musk fight is on: Meta launches 'Twitter Killer' Threads app
Brief: GSA Capital Partners LLP Reports 15.2% Passive Stake In T2 Biosystems As Of 28 June - SEC Filing
Brief: T2 Biosystems Shares Failed To Comply With MVLS Required For Continued Listing On Nasdaq
Brief: John Markey Reports 9.9% Passive Stake In T2 Biosystems Inc As Of June 12 - SEC Filing
Brief: T2 Biosystems Announces Submission For FDA Breakthrough Device Designation For Candida Auris Diagnostic Test
T2 Biosystems rises on contract for its sepsis-detecting diagnostics system
Brief: T2 Biosystems Announces Second Largest Sepsis-Driven Instrument Sale In Company History
U.S. RESEARCH ROUNDUP-Empire State, Integra Lifesciences, Lowe's Companies
Brief: T2 Biosystems Inc - On May 23, Got Letter From Nasdaq Informing Us That Our Shares Have Failed To Comply With Mvls Required For Continued Listing
T2 Biosystems falls after raising going concern doubt
Brief: T2 Biosystems Announces Q1 2023 Financial Results
Brief: T2 Biosystems Announces Exploration Of Strategic Alternatives And Implementation Of Restructuring Program
Brief: T2 Biosystems Announces FDA 510(K) Submission For The T2Biothreat Panel
T2 Biosystems Inc reports results for the quarter ended in March - Earnings Summary
T2 Biosystems Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: T2 Biosystems Postpones Q1 2023 Earnings Release